The Hain Celestial Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAIN research report →
Range $1 – $1
Price Chart
About the company
Hain Celestial Group, Inc. is a global enterprise dedicated to the production, marketing, and distribution of organic and natural consumer goods. Its operations are organized into two primary geographical segments: North America and International.
- CEO
- Alison E. Lewis
- IPO
- 1994
- Employees
- 2,600
- HQ
- Hoboken, NY, US
Get TickerSpark's AI analysis on HAIN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $53.04M
- P/E
- -0.10
- Fwd P/E
- 9.13
- PEG
- 0.00
- P/S
- 0.04
- P/B
- 0.25
- EV/EBITDA
- -1.52
- Div Yield
- 0.00%
- Gross Margin
- 19.26%
- Op Margin
- 2.19%
- Net Margin
- -35.47%
- ROE
- -140.70%
- ROIC
- 3.63%
Latest fiscal year · YoY change
- Revenue
- $1.56B-10.2%
- Gross Profit
- $327.62M-14.0%
- Op Income
- $56.51M
- Net Income
- $-530,841,000-607.4%
- EPS
- $-5.89-601.2%
- OCF Growth
- -81.0%
- FCF Growth
- -103.8%
- 52W High
- $2.17
- 52W Low
- $0.48
- 50D MA
- $0.57
- 200D MA
- $0.85
- Beta
- 0.73
- RSI (14)
- 52
- Avg Volume
- 1.06M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Hain Celestial said Q3 showed better execution and stronger cash generation, but sales were below expectations as the company leaned on innovation, portfolio simplification, and debt reduction.· May 11, 2026
- Q3 adjusted EBITDA was $26 million, with adjusted EBITDA margin improving to 7.8% from 6.3% in Q2.
- Organic net sales fell 6% year over year, driven mainly by International; North America organic sales declined 3%.
- Adjusted gross margin was 21%, down about 90 bps year over year but up about 150 bps sequentially.
- Free cash flow was $35 million versus an outflow of $2 million a year ago, and net debt fell to $505 million.
- Management said North America snacks divestiture makes the remaining business more focused and that Q4 organic sales should improve as innovation rolls out and the baby-food comparison eases.
Reported Q3 results included organic net sales down 6% year over year, adjusted gross margin of 21% (about 90 basis points lower year over year), SG&A down 6% to $59 million, adjusted EBITDA of $26 million versus $34 million a year ago, adjusted net loss of $1 million or $0.01 per diluted share versus adjusted net income of $6 million or $0.07 per share, and free cash flow of $35 million versus an outflow of $2 million last year. North America organic net sales declined 3% and International organic net sales declined 8%. For the balance of fiscal 2026, management did not provide numeric operating guidance because of the strategic review, but said it still expects positive full-year free cash flow, North America excluding snacks should have gross margin above 30% and EBITDA margin in the low double digits, and Q4 organic trends should improve. The company also expects approximately $20 million of capital expenditures for fiscal 2026 and said stranded costs are now expected in the high end of the $20 million to $25 million range.
Alison Lewis framed the quarter as evidence that the turnaround is taking hold, emphasizing improved execution, financial discipline, and a more focused portfolio after the snacks divestiture. She repeatedly pointed to innovation as a differentiator, with launches in tea, baby & kids, yogurt, and international categories intended to drive trial, distribution, and share gains. Her tone was constructive but measured: she acknowledged organic sales were weaker than expected and said the team is actively addressing isolated challenges while keeping the focus on sustainable, profitable growth.
Lee Boyce highlighted the financial mechanics of the quarter: organic net sales down 6%, adjusted gross margin at 21%, SG&A down 6% to $59 million, adjusted EBITDA of $26 million, and free cash flow of $35 million. He said cash on hand rose to $44 million and net debt declined to $505 million, down $145 million since fiscal year start, with $196 million available on the revolver and leverage at 4.3x versus a 5.5x covenant. He also said about 70% of stranded costs have already been removed, restructuring charges taken are $108 million out of expected $115 million to $125 million, and the company remains focused on debt reduction and addressing the December maturity.
Analysts pressed on how Hain plans to fund and support innovation without sacrificing deleveraging, and management said marketing spend will be balanced and more targeted, with a heavier digital/social mix and investment tied to launches. Questions also focused on private label pressure and competitive promotions; management said North America private label is mostly low share outside yogurt and pantry, while International is seeing more private-label pressure, so spending will be surgical. On Meal Prep and branded non-dairy, management said yogurt and innovation-led subsegments are driving momentum, while pantry brands remain more challenged and are being stabilized with retailer-specific trade and marketing support.
The bull case from the call is that the turnaround is showing through in margins, cash, and debt reduction even though sales are still uneven. Management pointed to multiple core categories with momentum — tea, Greek Gods yogurt, Earth’s Best finger foods and cereal — plus a stronger innovation pipeline and a more focused North America portfolio with gross margin above 30% and low-double-digit EBITDA margin potential. They also said Q4 trends should improve as innovation launches and baby-food comparisons ease.
The bear case is that organic sales still declined 6% overall and International remains under meaningful pressure from weak volume, private label competition, and category softness. Management acknowledged that some categories, including wet baby food, spreads and drizzles, and parts of soup and pantry, are still challenged, and that revenue came in below expectations. The company is also working through a December debt maturity and has withheld numeric fiscal 2026 operating guidance because of the strategic review.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.1%
- Shares Outstanding
- 90.25M
- Float Shares
- 87.63M
of shares held by institutions
171 13F filers
Buy/sell ratio 0.96. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HAIN, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Peter WelchHouse · VT00 | Sell | Nov 8, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 7.12M | ▲ 92.39K |
| Two Sigma Advisers, LP | 1.84M | ▲ 6.40K |
| Cwm, LLC | 112.59K | ▲ 59.80K |
| Point72 Asia (Singapore) Pte. Ltd. | 66.29K | ▼ 12.82K |
| Nj State Employees Deferred Compensation Plan | 27.00K | 0 |
| Wolverine Trading, LLC | 14.56K | ▼ 1.78K |
| Cubist Systematic Strategies, LLC | 4.44K | ▼ 115.82K |
| Comerica Bank | 2.79K | ▲ 1.02K |
| Quest Partners LLC | 2.05K | 0 |
| Parkside Financial Bank & Trust | 520 | ▲ 520 |
| Parkworth Wealth Management, Inc. | 156 | ▲ 156 |
Held by 58 ETFs
Biggest fund positions in HAIN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 15, 25 | LEWIS ALISON | other | 96,003 |
| Dec 18, 25 | Taylor Carlyn R. | sell | 53,957 |
| Dec 12, 25 | Ragusa Michael | other | 53,334 |
| Dec 12, 25 | Meringolo Kristy | other | 155,556 |
| Dec 12, 25 | Goldenitsch Wolfgang | other | 155,556 |
| Dec 12, 25 | Boyce Lee A. | other | 244,445 |
| Dec 15, 25 | LEWIS ALISON | other | 1,500,000 |
| Dec 15, 25 | LEWIS ALISON | other | 650,000 |
| Dec 15, 25 | LEWIS ALISON | other | 377,515 |
| Dec 15, 25 | LEWIS ALISON | other | 124,281 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HAIN coverage
Recent articles, reports, and earnings notes.
No research on HAIN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HAIN report →Hain Celestial Announces Fiscal 2026 Fourth Quarter and Full Year Financials Results Conference Call and Webcast
globenewswire.com · Aug 17
Celestial Seasonings® Expands Anytime Wellness Tea Line with Three New Functional Blends
globenewswire.com · Jul 30
Critical Analysis: The Hain Celestial Group (NASDAQ:HAIN) vs. Celsius (NASDAQ:CELH)
defenseworld.net · Jul 28
Natural Food Stocks Gain From Health and Sustainability Trends
zacks.com · Jun 12
Why Is Hain Celestial (HAIN) Down 18.6% Since Last Earnings Report?
zacks.com · Jun 10
HAIN Stock Jumps 10% Despite Reporting Q2 Loss & Y/Y Sales Decline
zacks.com · May 12
The Hain Celestial Group, Inc. (HAIN) Q3 2026 Earnings Call Transcript
seekingalpha.com · May 11
Hain Celestial (HAIN) Reports Q3 Loss, Lags Revenue Estimates
zacks.com · May 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.